enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ezetimibe - Wikipedia

   en.wikipedia.org/wiki/Ezetimibe

   Ezetimibe works by decreasing cholesterol absorption in the intestines. [5] Ezetimibe was approved for medical use in the United States in 2002. [4] It is available as a generic medication. [5] In 2022, it was the 79th most commonly prescribed medication in the United States, with more than 8 million prescriptions. [11] [12]

3. Ezetimibe/simvastatin - Wikipedia

   en.wikipedia.org/wiki/Ezetimibe/simvastatin

   It is a combination of ezetimibe (known as Zetia in the United States) and the statin drug simvastatin (known as Zocor in the US). Ezetimibe reduces blood cholesterol by acting at the brush border of the small intestine and inhibiting the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.

4. Ezetimibe/atorvastatin - Wikipedia

   en.wikipedia.org/wiki/Ezetimibe/atorvastatin

   Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug.In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [1]

5. FDA Approves Powerful New Cholesterol Drug

   www.aol.com/news/2013-05-03-fda-approves...

   Merck gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer's Lipitor and Merck's Zetia. Merck already ...

6. FDA approves drug that lowers cholesterol in a new way

   www.aol.com/news/fda-approves-drug-lowers...

   U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can't tolerate — or don't get enough help from — widely used statin pills like ...

7. Cholesterol absorption inhibitor - Wikipedia

   en.wikipedia.org/wiki/Cholesterol_absorption...

   Cholesterol absorption inhibitors are known to have a synergistic effect when combined a class of antihyperlipidemics called statins, to achieve an overall serum cholesterol target. For statin-resistant or statin-sensitive populations that are characterized by low one-year compliance rates, such a combination therapy is proving to be especially ...